DNAprint Genomics (DNAG)

[mingwan0]

ifida, the following statistics are worth repeating:

"The FDA estimates that 2.4 million patients had adverse drug reactions in 2000, leading to the deaths of more than 125,000 patients. Adverse drug reactions represent the fourth leading cause of death in the United States."

Let me put that in perspective for you all. Candlestick Park seats about 70,000 people, so it's roughly 1.8 times that many people who die from ADR (every year).

To a lot of us this is comfortably in the blindingly obvious category. In an ideal world the FDA would be able to fast track this and devote resources to mimimize the timescales. Of course we don't live in an ideal world. This article highlights some of the issues that fast-tracking this stuff entails:

http://www.businessweek.com/magazine/content/03_22/b3835719.htm

Is Mark McClellan the right person to resolve this? Pros and cons certainly. Anybody else have a view?